Osaic Holdings’s Palvella Therapeutics PVLA Stock Holding History

Osaic Holdings’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.49K	Buy	20 +18	+900%	+$1.88K	﹤0.01%	6968
2025 Q4	$209	Sell	2 -12	-86%	-$1.02K	﹤0.01%	7575
2025 Q3	$878	Buy	+14	New	+$624	﹤0.01%	7404
2025 Q1	–	Sell	-7	Closed	-$84	–	7782
2024 Q4	$84	Hold	7	–	–	﹤0.01%	7260
2024 Q3	$116	Hold	7	–	–	﹤0.01%	7234
2024 Q2	$69	Buy	7 +1	+17%	+$11	﹤0.01%	7284
2024 Q1	$95	Hold	6	–	–	﹤0.01%	7041
2023 Q4	$94	Hold	6	–	–	﹤0.01%	7115
2023 Q3	$154	Hold	6	–	–	﹤0.01%	7187
2023 Q2	$85	Hold	6	–	–	﹤0.01%	7299
2023 Q1	$504	Hold	6	–	–	﹤0.01%	7128
2022 Q4	$1K	Sell	6 -25	-81%	-$2.01K	﹤0.01%	6997
2022 Q3	$3K	Hold	31	–	–	﹤0.01%	6687
2022 Q2	$5K	Hold	31	–	–	﹤0.01%	6513
2022 Q1	$8K	Hold	31	–	–	﹤0.01%	6288
2021 Q4	$10K	Buy	31 +6	+24%	+$1.92K	﹤0.01%	6266
2021 Q3	$10K	Hold	25	–	–	﹤0.01%	6214
2021 Q2	$8K	Buy	+25	New	+$5.48K	﹤0.01%	6219
2020 Q4	–	Sell	-8	Closed	-$1K	–	6615
2020 Q3	$1K	Hold	8	–	–	﹤0.01%	6097
2020 Q2	$2K	Hold	8	–	–	﹤0.01%	5843
2020 Q1	$1K	Buy	+8	New	+$2.02K	﹤0.01%	5950

Other funds holding PVLA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Osaic Holdings's PVLA Position: Q1 2026 in Review

Osaic Holdings increased its Palvella Therapeutics (PVLA) stake by 900% in Q1 2026, buying an estimated $1.88K and bringing the position to 20 shares worth $2.49K. The position accounts for ﹤0.01% of the portfolio, ranked #6968.

Osaic Holdings first reported a position in PVLA in Q1 2020 and has held it in 21 quarters since. The position peaked at $10K in Q4 2021. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

Osaic Holdings held 20 shares of Palvella Therapeutics worth $2.49K as of Q1 2026.
Osaic Holdings bought 18 Palvella Therapeutics shares in Q1 2026, an estimated $1.88K.
Palvella Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6968 holding.
Osaic Holdings first reported a position in Palvella Therapeutics in Q1 2020 and has held it in 21 quarters since.
Osaic Holdings's Palvella Therapeutics position peaked at $10K in Q4 2021.
180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.